- Home
- IMMX vs CULP Comparison
IMMX vs CULP Comparison
Compare IMMX & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- CULP
- Stock Information
- Founded
- IMMX 2014
- CULP 1972
- Country
- IMMX United States
- CULP United States
- Employees
- IMMX N/A
- CULP N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- CULP Textiles
- Sector
- IMMX Health Care
- CULP Consumer Discretionary
- Exchange
- IMMX Nasdaq
- CULP Nasdaq
- Market Cap
- IMMX 61.1M
- CULP 50.9M
- IPO Year
- IMMX 2021
- CULP N/A
- Fundamental
- Price
- IMMX $2.65
- CULP $4.26
- Analyst Decision
- IMMX Strong Buy
- CULP
- Analyst Count
- IMMX 1
- CULP 0
- Target Price
- IMMX $7.00
- CULP N/A
- AVG Volume (30 Days)
- IMMX 220.7K
- CULP 12.9K
- Earning Date
- IMMX 08-11-2025
- CULP 09-03-2025
- Dividend Yield
- IMMX N/A
- CULP N/A
- EPS Growth
- IMMX N/A
- CULP N/A
- EPS
- IMMX N/A
- CULP N/A
- Revenue
- IMMX N/A
- CULP $213,237,000.00
- Revenue This Year
- IMMX N/A
- CULP $2.41
- Revenue Next Year
- IMMX N/A
- CULP $3.46
- P/E Ratio
- IMMX N/A
- CULP N/A
- Revenue Growth
- IMMX N/A
- CULP N/A
- 52 Week Low
- IMMX $1.26
- CULP $3.42
- 52 Week High
- IMMX $3.20
- CULP $6.85
- Technical
- Relative Strength Index (RSI)
- IMMX 49.64
- CULP 46.40
- Support Level
- IMMX $2.63
- CULP $4.25
- Resistance Level
- IMMX $3.20
- CULP $4.57
- Average True Range (ATR)
- IMMX 0.22
- CULP 0.18
- MACD
- IMMX -0.04
- CULP -0.04
- Stochastic Oscillator
- IMMX 3.51
- CULP 15.38
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About CULP Culp Inc.
Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.